EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors

Alejandra Barrón-Hernández, Juan Alberto Ríos-Rodríguez, José Antonio García-Pacheco, Berenice Cuevas-Estrada, Sebastián De-la-Rosa, Clementina Castro-Hernández, Miguel A Jiménez-Ríos, Nora Sobrevilla-Moreno, Miguel Santibáñez-Andrade, Rodrigo González-Barrios iD

The Oncologist · 10.04.2026 · 31 (5)

DOI: 10.1093/oncolo/oyag072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 16.04.2026. Verfasst von Alejandra Barrón-Hernández und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Regulación de la Cromatina y Genómica, Instituto Nacional de Cancerología, Mexico City, 14080, Mexico. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Muscle, Skeletal, Metabolome. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Cancerología (INCan), Financiamiento de Proyectos de Investigación para la Salud Program, Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Testicular germ cell tumors (TGCT) are highly curable malignancies, yet the prognostic impact of host metabolic status remains underexplored, especially in non-Caucasian populations.

Methods

We analyzed 2755 Mexican patients with TGCT treated at the Instituto Nacional de Cancerología (2007-2021). A Metabolic sub-cohort (n = 586) and an Imaging sub-cohort (n = 231) with baseline CT-derived lean mass index (LMI) were evaluated. Statistical analyses included multivariate Cox regression adjusted for IGCCCG risk, principal component analysis (PCA)-based clustering, and internal validation using bootstrapping.

Results

Multivariate Cox regression adjusted for IGCCCG risk identified LMI (HR 0.95, 95% CI 0.90-0.99, P = .047), serum albumin (HR 0.27, 95% CI 0.18-0.42, P < .001), and HDL cholesterol (HR 0.94, 95% CI 0.91-0.96, P < .001) as independently associated factors. PCA-based metabolic-nutritional risk profiles effectively stratified 5-year survival in patients with non-seminoma (from 16.1% in depleted profiles to 97.4% in preserved profiles) and seminoma (64.0% vs 100%). A reduced prognostic model (BMI, LMI, albumin) achieved a robust optimism-corrected AUC of 0.866.

Conclusions

Metabolic and body composition profiling provides prognostic discrimination complementary to the IGCCCG classification, suggesting the potential utility of incorporating objective nutritional assessments. Early identification of patients with metabolic vulnerability—specifically hypoalbuminemia, skeletal muscle depletion, and altered lipid profiles—could help guide personalized supportive strategies prioritizing nutritional and medical optimization to improve outcomes in TGCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsNeoplasms, Germ Cell and EmbryonalMuscle, SkeletalMetabolomeHumansMaleAdultPrognosisMiddle Aged

Stichwörter der Autor:innen

TGCTalbuminbody mass indexcancer survivallean mass indextesticular cancer

Autor:innen und Institutionen

  • Laboratorio de Regulación de la Cromatina y Genómica, Instituto Nacional de Cancerología, Mexico City, 14080, Mexico.
  • Departamento de Urología, Instituto Nacional de Cancerología, Mexico City, 14080, Mexico.
  • Departamento de Oncología Médica, Instituto Nacional de Cancerología, Mexico City, 14080, Mexico.
  • Departamento de Biología Celular, Facultad de Ciencias, UNAM, Mexico City, 04510, Mexico.

ORCID-Profile: Rodrigo González-Barrios

Förderung

  • Instituto Nacional de Cancerología (INCan)
  • Financiamiento de Proyectos de Investigación para la Salud Program
  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI)
  • Ciencia de Frontera Program

Zitieren

APA

Barrón-Hernández, A., Ríos-Rodríguez, J. A., García-Pacheco, J. A., Cuevas-Estrada, B., De-la-Rosa, S., Castro-Hernández, C., Jiménez-Ríos, M. A., Sobrevilla-Moreno, N., Santibáñez-Andrade, M., & González-Barrios, R. (2026). Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors. The Oncologist, 31(5). https://doi.org/10.1093/oncolo/oyag072

Vancouver

Barrón-Hernández A, Ríos-Rodríguez JA, García-Pacheco JA, Cuevas-Estrada B, De-la-Rosa S, Castro-Hernández C, et al. Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors. The Oncologist. 2026;31(5). doi:10.1093/oncolo/oyag072

BibTeX
@article{BarrnHernndez2026,
  author = {Barrón-Hernández, Alejandra and Ríos-Rodríguez, Juan Alberto and García-Pacheco, José Antonio and Cuevas-Estrada, Berenice and De-la-Rosa, Sebastián and Castro-Hernández, Clementina and Jiménez-Ríos, Miguel A and Sobrevilla-Moreno, Nora and Santibáñez-Andrade, Miguel and González-Barrios, Rodrigo},
  title = {Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.1093/oncolo/oyag072}
}
Kostenlos starten →